This synthetic IL‐2 pathway induces potent TCR‐T or CAR‐T cell infiltration and effective tumor regression in immune‐excluded solid tumor models while avoiding associated systemic or off‐target toxicities.[155]. Here, IL2 is linked to neoplasm.